World Incretin-Based Drugs Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets

DUBLIN--()--The "World Incretin-Based Drugs Market - Opportunities and Forecasts, 2014 - 2022" report has been added to Research and Markets' offering.

Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs.

KEY MARKET BENEFITS:

  • Comprehensive analysis of factors that drive and restrict the growth of the global incretin-based drugs market is provided
  • The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
  • An in-depth analysis of key segments of the market demonstrates the types of drugs and formulations that are currently being used along with the variants that would gain prominence in future
  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
  • Region-wise incretin-based drugs market conditions are comprehensively analyzed in the report

KEY MARKET SEGMENTS:

Global Incretin Based Drugs Market - By Drug Type

  • Glucagon-like peptide-1 receptor (GLP-1) agonists
  • Dipeptidyl Peptidase-4 (DPP-4) inhibitors

Global Incretin Based Drugs Market - By Formulation

  • Oral Drugs
  • Injectable Drugs

Global Incretin Based Drugs Market - By Geography

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

For more information about this report visit https://www.researchandmarkets.com/research/jv99jm/world

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs